Table 1 |
|||
|
Comparison of baseline clinical demographics of test and control groups |
|||
|
Control Group |
Test Group |
P |
|
|
Categories |
(N = 18) |
(N = 18) |
|
|
|
|||
|
Clinical assessment at entry |
|||
|
Age (Years) |
62.8 ± 11.4 |
59.7 ± 14.9 |
NS† |
|
RA duration (Months) |
88.1 ± 76.2 |
114.5 ± 92.6 |
NS† |
|
DAS28-ESR |
5.64 ± 0.86 |
5.64 ± 1.37 |
NS† |
|
TJC |
12.3 ± 6.1 |
15.9 ± 11.7 |
NS† |
|
SJC |
12.6 ± 6.2 |
13.9 ± 7.8 |
NS† |
|
ESR (mm/hr) |
46.7 ± 27.0 |
48.4 ± 32.9 |
NS† |
|
CRP (mg/dl) |
2.5 ± 2.4 |
2.5 ± 2.8 |
NS† |
|
RF (IU/ml) |
143 ± 102 |
213 ± 292 |
NS† |
|
|
|||
|
Medication |
|||
|
PSL (mg/day) |
2.72 ± 2.29 |
2.64 ± 2.94 |
NS† |
|
PSL (No.) |
13 |
11 |
NS§ |
|
DMARDs (No.) |
16 |
13 |
NS§ |
|
NSAIDs (No.) |
14 |
11 |
NS§ |
|
|
|||
|
Ochi's Classification |
|||
|
LES |
3 (17%) |
4 (22%) |
NS§ |
|
MES |
12 (66%) |
10 (56%) |
NS§ |
|
MUD |
3 (17%) |
4 (22%) |
NS§ |
|
|
|||
|
Complications and risk factor |
|||
|
Complication (No.) |
9 |
9 |
NS§ |
|
Drug resistance (No.) |
7 |
5 |
NS§ |
|
Drug allergy (No.) |
2 |
4 |
NS§ |
|
|
|||
|
Gastrointestinal Disorders |
|||
|
Constipation (No.) |
12 |
12 |
NS§ |
|
Diarrhea (No.) |
3 |
2 |
NS§ |
|
None (No.) |
3 |
4 |
NS§ |
|
|
|||
|
Data is shown as the mean ± standard deviation. TJC: tender joint count, SJC: swollen joint count, RF: rheumatoid factor, PSL: Prednisolone, LES: least erosive subset, MES: more erosive subset, MUD: mutilating disease, NS: Not significant. †: Determined by Mann Whitney U-test. §: Determined by Chi square test. |
|||
|
Katayama et al. Nutrition Journal 2011 10:2 doi:10.1186/1475-2891-10-2 |
|||
